297 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 6 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
CERCAMCerebral endothelial cell adhesion moleculePredicted intracellular proteins
Predicted secreted proteins
Nucleus
Nucleoli
Cell Junctions
Renal cancer: 3.33e-16
Urothelial cancer: 3.30e-5
Ovarian cancer: 5.22e-4
Expressed in all
CFAP206Cilia and flagella associated protein 206Predicted intracellular proteins
Nucleoplasm
Cell Junctions
Group enriched
CFBComplement factor BDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Cell Junctions
Renal cancer: 1.53e-5
Breast cancer: 2.76e-5
Tissue enriched
CGNCingulinPlasma proteins
Predicted intracellular proteins
Plasma membrane
Cell Junctions
Renal cancer: 5.84e-10
Tissue enhanced
CGNL1Cingulin like 1Disease related genes
Predicted intracellular proteins
Cell JunctionsRenal cancer: 1.37e-6
Endometrial cancer: 3.55e-4
Liver cancer: 5.58e-4
Mixed
CHCHD7Coiled-coil-helix-coiled-coil-helix domain containing 7Cancer-related genes
Disease related genes
Predicted intracellular proteins
Cell Junctions
Aggresome
Endometrial cancer: 1.39e-6
Renal cancer: 9.47e-5
Expressed in all
CLCA2Chloride channel accessory 2Predicted membrane proteins
Nucleus
Plasma membrane
Cell Junctions
Group enriched
CLDN2Claudin 2Predicted membrane proteins
Nucleoplasm
Cell Junctions
Thyroid cancer: 1.70e-4
Tissue enhanced
CLDN3Claudin 3Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Cell JunctionsRenal cancer: 3.39e-5
Tissue enhanced
CLDN7Claudin 7Cancer-related genes
Predicted membrane proteins
Predicted secreted proteins
Transporters
Vesicles
Cell Junctions
Renal cancer: 8.96e-11
Thyroid cancer: 1.85e-4
Stomach cancer: 4.09e-4
Mixed
CLDN9Claudin 9Predicted membrane proteins
Vesicles
Cell Junctions
Endometrial cancer: 2.24e-6
Stomach cancer: 4.67e-4
Tissue enhanced
CLSTN2Calsyntenin 2Predicted membrane proteins
Nucleoplasm
Nuclear membrane
Cell Junctions
Tissue enhanced
CMTR2Cap methyltransferase 2Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Nuclear speckles
Cell Junctions
Renal cancer: 4.97e-5
Expressed in all
COBLCordon-bleu WH2 repeat proteinPredicted intracellular proteins
Plasma membrane
Cell Junctions
Renal cancer: 5.21e-12
Mixed
COBLL1Cordon-bleu WH2 repeat protein like 1Predicted intracellular proteins
Cell JunctionsRenal cancer: 5.27e-13
Mixed
COLEC12Collectin subfamily member 12Predicted membrane proteins
Golgi apparatus
Vesicles
Cell Junctions
Thyroid cancer: 8.10e-4
Tissue enhanced
COLQCollagen like tail subunit of asymmetric acetylcholinesteraseDisease related genes
Predicted intracellular proteins
Predicted secreted proteins
Plasma membrane
Cell Junctions
Tissue enhanced
CRB3Crumbs 3, cell polarity complex componentPredicted membrane proteins
Cell JunctionsRenal cancer: 0.00e+0
Urothelial cancer: 8.06e-5
Endometrial cancer: 4.54e-4
Mixed
CTNNA1Catenin alpha 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cell Junctions
Renal cancer: 7.34e-7
Pancreatic cancer: 8.02e-4
Expressed in all
CTNNBIP1Catenin beta interacting protein 1Predicted intracellular proteins
Plasma membrane
Cell Junctions
Mitochondria
Endometrial cancer: 5.68e-6
Expressed in all
CTNND2Catenin delta 2Disease related genes
Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Cell Junctions
Tissue enriched
CTXN1Cortexin 1Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cell Junctions
Tissue enhanced
CXADRCoxsackie virus and adenovirus receptorPredicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cell Junctions
Head and neck cancer: 3.50e-4
Mixed
CYP20A1Cytochrome P450 family 20 subfamily A member 1Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cell Junctions
Actin filaments
Mixed
DCAF13DDB1 and CUL4 associated factor 13Predicted intracellular proteins
Nucleus
Nucleoli
Cell Junctions
Centrosome
Cytosol
Liver cancer: 8.05e-6
Renal cancer: 2.85e-4
Breast cancer: 4.06e-4
Expressed in all
DCP2Decapping mRNA 2Enzymes
Predicted intracellular proteins
Nucleoplasm
Cell Junctions
Cytoplasmic bodies
Renal cancer: 2.66e-5
Liver cancer: 4.84e-4
Mixed
DDB2Damage specific DNA binding protein 2Cancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cell Junctions
Endometrial cancer: 1.20e-4
Cervical cancer: 1.58e-4
Breast cancer: 7.29e-4
Expressed in all
DDR1Discoidin domain receptor tyrosine kinase 1CD markers
Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Cell Junctions
Renal cancer: 3.31e-10
Mixed
DHRS7BDehydrogenase/reductase 7BPredicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Cytosol
Endometrial cancer: 1.98e-8
Renal cancer: 3.95e-5
Expressed in all
DLG5Discs large MAGUK scaffold protein 5Predicted intracellular proteins
Cell JunctionsLiver cancer: 5.38e-4
Mixed
DLX1Distal-less homeobox 1Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles
Cell Junctions
Tissue enhanced
DNAJC18DnaJ heat shock protein family (Hsp40) member C18Predicted intracellular proteins
Predicted membrane proteins
Cell JunctionsPancreatic cancer: 5.89e-4
Group enriched
DOC2ADouble C2 domain alphaPredicted intracellular proteins
Nucleus
Nucleoli
Cell Junctions
Group enriched
DONSONDownstream neighbor of SONPlasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cell Junctions
Cytosol
Renal cancer: 0.00e+0
Ovarian cancer: 2.17e-4
Liver cancer: 8.22e-4
Tissue enhanced
DPEP1Dipeptidase 1 (renal)Enzymes
FDA approved drug targets
Predicted secreted proteins
Nucleus
Cell Junctions
Renal cancer: 6.84e-4
Tissue enhanced
DPH1Diphthamide biosynthesis 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cell Junctions
Pancreatic cancer: 1.78e-5
Expressed in all
DSC3Desmocollin 3Disease related genes
Plasma proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Urothelial cancer: 1.04e-5
Group enriched
DSG2Desmoglein 2Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cell Junctions
Renal cancer: 3.14e-10
Pancreatic cancer: 4.94e-5
Lung cancer: 2.43e-4
Head and neck cancer: 5.63e-4
Colorectal cancer: 7.81e-4
Cervical cancer: 8.22e-4
Tissue enhanced
DSPDesmoplakinDisease related genes
Plasma proteins
Predicted intracellular proteins
Cell JunctionsRenal cancer: 1.53e-9
Urothelial cancer: 1.82e-4
Group enriched
DTNADystrobrevin alphaDisease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cell Junctions
Intermediate filaments
Renal cancer: 2.64e-7
Tissue enhanced
EDA2REctodysplasin A2 receptorPredicted membrane proteins
Cell JunctionsMixed
EFCAB11EF-hand calcium binding domain 11Predicted intracellular proteins
Cell Junctions
Cytosol
Tissue enhanced
ELFN1Extracellular leucine rich repeat and fibronectin type III domain containing 1Predicted membrane proteins
Nucleoplasm
Cell Junctions
Liver cancer: 9.68e-4
Tissue enhanced
ELMO3Engulfment and cell motility 3Predicted intracellular proteins
Plasma membrane
Cell Junctions
Renal cancer: 2.77e-5
Mixed
ELOCElongin CPlasma proteins
Predicted intracellular proteins
Cell JunctionsBreast cancer: 6.48e-4
Expressed in all
EMC4ER membrane protein complex subunit 4Predicted intracellular proteins
Predicted membrane proteins
Cell Junctions
Focal adhesion sites
Expressed in all
EPB41Erythrocyte membrane protein band 4.1Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membrane
Cell Junctions
Cytosol
Renal cancer: 1.75e-6
Endometrial cancer: 4.58e-4
Head and neck cancer: 5.87e-4
Expressed in all
EPB41L2Erythrocyte membrane protein band 4.1 like 2Plasma proteins
Predicted intracellular proteins
Nucleus
Plasma membrane
Cell Junctions
Liver cancer: 2.41e-5
Ovarian cancer: 2.16e-4
Expressed in all
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
Nuclear speckles
Golgi apparatus
Plasma membrane
Cell Junctions
Tissue enhanced
F11RF11 receptorCD markers
Plasma proteins
Predicted membrane proteins
Cell Junctions
Microtubules
Expressed in all
« prev | Page of 6 | next »